C4XD signs NRF2 Activator deal with AstraZeneca
C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial
Read More
Tag: C4XD
C4XD forms discovery partnership with AI company GTN
C4X Discovery has entered into a drug discovery partnership with artificial intelligence (AI) company GTN.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
